Verdence Capital Advisors’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-36,835
Closed -$1.22M 591
2023
Q3
$1.22M Sell
36,835
-11,659
-24% -$372K 0.13% 178
2023
Q2
$1.49M Buy
48,494
+1,308
+3% +$37.8K 0.17% 149
2023
Q1
$1.29M Buy
47,186
+22,106
+88% +$615K 0.16% 157
2022
Q4
$701K Sell
25,080
-13,742
-35% -$414K 0.09% 228
2022
Q3
$1.15M Buy
38,822
+1,809
+5% +$56.7K 0.16% 151
2022
Q2
$1.04M Buy
37,013
+1,627
+5% +$46.3K 0.13% 172
2022
Q1
$1.1M Buy
35,386
+5,356
+18% +$158K 0.13% 180
2021
Q4
$889K Buy
30,030
+279
+0.9% +$8.15K 0.1% 196
2021
Q3
$891K Buy
29,751
+5,404
+22% +$186K 0.12% 186
2021
Q2
$884K Buy
24,347
+4,844
+25% +$180K 0.12% 178
2021
Q1
$714K Buy
19,503
+832
+4% +$30.6K 0.12% 177
2020
Q4
$678K Buy
18,671
+4,689
+34% +$159K 0.13% 166
2020
Q3
$419K Buy
13,982
+3,374
+32% +$105K 0.1% 213
2020
Q2
$315K Buy
+10,608
New +$314K 0.08% 231

Other funds holding OHI

Verdence Capital Advisors's OHI Position: Q4 2023 in Review

Verdence Capital Advisors sold out of Omega Healthcare (OHI) in Q4 2023, closing a stake of 36,835 shares — an estimated $1.22M sold.

Verdence Capital Advisors first reported a position in OHI in Q2 2020 and held it in 14 quarters. The position peaked at $1.49M in Q2 2023. 528 funds tracked by Wall St. Rank hold OHI as of Q4 2023.

  • Verdence Capital Advisors reported no remaining Omega Healthcare position as of Q4 2023 after selling out during the quarter.
  • Verdence Capital Advisors sold 36,835 Omega Healthcare shares in Q4 2023, an estimated $1.22M.
  • Verdence Capital Advisors first reported a position in Omega Healthcare in Q2 2020 and held it in 14 quarters.
  • Verdence Capital Advisors's Omega Healthcare position peaked at $1.49M in Q2 2023.
  • 528 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2023.

Based on Verdence Capital Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.